Cargando…

CytoSorb hemoperfusion markedly attenuates circulating cytokine concentrations during systemic inflammation in humans in vivo

BACKGROUND: The CytoSorb hemoadsorption device has been demonstrated to be capable of clearing inflammatory cytokines, but has not yet been shown to attenuate plasma cytokine concentrations. We investigated the effects of CytoSorb hemoperfusion on plasma levels of various cytokines using the repeate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jansen, Aron, Waalders, Nicole J. B., van Lier, Dirk P. T., Kox, Matthijs, Pickkers, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10029173/ https://www.ncbi.nlm.nih.gov/pubmed/36945034 http://dx.doi.org/10.1186/s13054-023-04391-z

Ejemplares similares

CytoSorb-friend or foe!!
por: Pattnaik, Saroj Kumar, et al.
Publicado: (2015)

Pancreatitis cytosorbents (CytoSorb) inflammatory cytokine removal: A Prospective Study (PACIFIC)
por: Huber, Wolfgang, et al.
Publicado: (2019)

Impact of CytoSorb® on interleukin-6 in cardiac surgery
por: Geisler, Daniela, et al.
Publicado: (2023)

Prevention of vasoplegia with CytoSorb in heart failure patients undergoing cardiac surgery (CytoSorb-HF trial): protocol for a randomised controlled trial
por: Papazisi, Olga, et al.
Publicado: (2022)

Hemoadsorption by CytoSorb in septic patients: a case series
por: Kogelmann, Klaus, et al.
Publicado: (2017)

CytoSorb removes MDMA in vitro, but is it an effective therapy in vivo?
por: Honore, Patrick M., et al.
Publicado: (2020)

Experience with hemoadsorption (CytoSorb(®)) in the management of septic shock patients
por: Mehta, Yatin, et al.
Publicado: (2020)

Pharmacokinetics of anti-infective agents during CytoSorb hemoadsorption
por: Schneider, Antoine G., et al.
Publicado: (2021)

Efficacy of CytoSorb®: a systematic review and meta-analysis
por: Becker, Sören, et al.
Publicado: (2023)

Cytokine hemoadsorption with CytoSorb® in patients with sepsis: a systematic review and meta-analysis
por: Saldaña-Gastulo, Jiovany Jhan Carlos, et al.
Publicado: (2023)

Role of Hemoperfusion With CytoSorb Associated With Continuous Kidney Replacement Therapy on Renal Outcome in Critically III Children With Septic Shock
por: Bottari, Gabriella, et al.
Publicado: (2021)

Hemadsorption with Adult CytoSorb® in a Low Weight Pediatric Case
por: Cirstoveanu, Catalin Gabriel, et al.
Publicado: (2017)

Use of CytoSorb in Traumatic Amputation of the Forearm and Severe Septic Shock
por: Steltzer, Heinz, et al.
Publicado: (2017)

Hemoadsorption in the critically ill—Final results of the International CytoSorb Registry
por: Hawchar, Fatime, et al.
Publicado: (2022)

Cytokine clearance with CytoSorb® during cardiac surgery: a pilot randomized controlled trial
por: Poli, Elettra C, et al.
Publicado: (2019)

CytoSorb® Hemoadsorption as a Promising Tool to Handle COVID-19-Induced Cytokine Storm
por: Acevedo, Alice-Christin, et al.
Publicado: (2021)

Impact of CytoSorb and CKRT on hemodynamics in pediatric patients with septic shock: the PedCyto study
por: Bottari, Gabriella, et al.
Publicado: (2023)

Hemoadsorption with CytoSorb(®) and the early course of linezolid plasma concentration during septic shock
por: Köhler, Thomas, et al.
Publicado: (2021)

Hemoadsorption of cytokines by CytoSorb filter: a simulation study without human factor—pilot is the difference
por: Nadeem, Rashid, et al.
Publicado: (2020)

Cytokine hemoadsorption with CytoSorb(®) in post-cardiac arrest syndrome, a pilot randomized controlled trial
por: Monard, Céline, et al.
Publicado: (2023)

No clinically relevant removal of meropenem by cytokine adsorber CytoSorb(®) in critically ill patients with sepsis or septic shock
por: Liebchen, Uwe, et al.
Publicado: (2021)

Hemoadsorption Treatment with CytoSorb® in Probable Hemophagocytic Lymphohistiocytosis: A Role as Adjunctive Therapy?
por: Ceruti, Samuele, et al.
Publicado: (2021)

Mechanistic Considerations and Pharmacokinetic Implications on Concomitant Drug Administration During CytoSorb Therapy
por: Scheier, Joerg, et al.
Publicado: (2022)

Hemoadsorption in ‘Liver Indication’—Analysis of 109 Patients’ Data from the CytoSorb International Registry
por: Ocskay, Klementina, et al.
Publicado: (2021)

Sublingual Microcirculatory Evaluation of Extracorporeal Hemoadsorption with CytoSorb® in Abdominal Sepsis: A Case Report
por: Duran, Servet, et al.
Publicado: (2022)

CytoSorb in patients with coronavirus disease 2019: A rapid evidence review and meta-analysis
por: Wei, Shilin, et al.
Publicado: (2023)

Use of the CytoSorb adsorption device in MDMA intoxication: a first-in-man application and in vitro study
por: Lang, Corinna N., et al.
Publicado: (2020)

Does adjunctive hemoadsorption with CytoSorb affect survival of COVID-19 patients on ECMO? Authors' response
por: Supady, Alexander, et al.
Publicado: (2021)

Therapeutic Modulation of the Host Defense by Hemoadsorption with CytoSorb(®)—Basics, Indications and Perspectives—A Scoping Review
por: Köhler, Thomas, et al.
Publicado: (2021)

Use of CytoSorb® hemoadsorption column during prolonged cardiopulmonary bypass in complex cardiac surgery patient
por: Alarie, Marianne, et al.
Publicado: (2022)

Artificial Liver Support with CytoSorb and MARS in Liver Failure: A Retrospective Propensity Matched Analysis
por: Popescu, Mihai, et al.
Publicado: (2023)

Hemoadsorption Using CytoSorb(®) in Patients with Infective Endocarditis: A German-Based Budget Impact Analysis
por: Rao, Cristina, et al.
Publicado: (2023)

Can the cytokine adsorber CytoSorb(®) help to mitigate cytokine storm and reduce mortality in critically ill patients? A propensity score matching analysis
por: Scharf, Christina, et al.
Publicado: (2021)

Use of CytoSorb therapy to treat critically ill coronavirus disease 2019 patients: a case series
por: Mehta, Yatin, et al.
Publicado: (2021)

The Use of CytoSorb Therapy in Critically Ill COVID-19 Patients: Review of the Rationale and Current Clinical Experiences
por: Ruiz-Rodríguez, Juan Carlos, et al.
Publicado: (2021)

Does adjunctive hemoadsorption with CytoSorb affect survival of COVID-19 patients on ECMO? A critical statement
por: Köhler, Thomas, et al.
Publicado: (2021)

The use of CytoSorb® in a prasugrel‐loaded patient undergoing emergent coronary artery bypass graft surgery
por: Moresco, Erich, et al.
Publicado: (2023)

Multicentered prospective investigator initiated study to evaluate the clinical outcomes with extracorporeal cytokine adsorption device (CytoSorb(®)) in patients with sepsis and septic shock
por: Paul, Rajib, et al.
Publicado: (2021)

Does the cytokine adsorber CytoSorb(®) reduce vancomycin exposure in critically ill patients with sepsis or septic shock? a prospective observational study
por: Scharf, Christina, et al.
Publicado: (2022)

CytoResc – “CytoSorb” Rescue for critically ill patients undergoing the COVID-19 Cytokine Storm: A structured summary of a study protocol for a randomized controlled trial
por: Stockmann, Helena, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_1ppkhqq77au6fmbp3ad2tltkj0